EU-wide tender
Conclusion of non-exclusive discount agreements pursuant to Section 130a (8) SGB V for the active ingredient combination Adapalene + Benzoyl Peroxide
Original title: Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit der Wirkstoffkombination Adapalen + Benzoylperoxid
“Conclusion of non-exclusive discount agreements pursuant to Section 130a (8) SGB V for the active ingredient combination Adapalene + Benzoyl Peroxide” is a eu-wide public tender in North Rhine-Westphalia. Offers are due by Tuesday, 10 November 2026, in 9 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 10 November 2026, 9 days left, 10:00
- Published
- 19 February 2025
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- North Rhine-Westphalia
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
Discount agreements for a medicinal product with an active ingredient combination are being procured for health insurance funds in North Rhine-Westphalia.
- The contract start date is the first of April 2025
- All interested companies can join under the same conditions
- Initial notification is possible upon receipt by the tenth of March 2025
- Required documents include, among others, a signed contract and proof of pharmaceutical law compliance
Summary made from the German notice and checked against it; the German original is authoritative.
Questions and answers
When is the deadline for offers?
Until Tuesday, 10 November 2026, 9 days left. The exact time and how to submit are in the original notice, which is authoritative.
Is this tender open to foreign companies?
Yes. Because it is above the EU thresholds, the procedure follows the EU directives, which rule out discrimination by nationality. Suitability can first be shown with the European Single Procurement Document (ESPD).
Where is the contract performed?
The place of performance is North Rhine-Westphalia.
In which language are the documents and the offer?
Expect German. The accepted languages are stated in the notice, and certificates in another language may have to be submitted with a translation.
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
Worth knowing before you bid
It can be renewed up to 2 times. The notice links the tender documents directly.
Deadlines and dates
| Published | Wednesday, 19 February 2025 |
|---|---|
| Deadline | Tuesday, 10 November 2026, 10:00 |
| Tender validity ends (calculated) | Thursday, 10 December 2026 |
| Start of performance | Tuesday, 1 April 2025 |
| End of performance | Thursday, 31 December 2026 |
Conditions stated in the notice
| Renewals | up to 2 |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
More open tenders in North Rhine-Westphalia
- Pharmaceutical Contracts with Option to Join
BARMER Beschaffung und Vergabe
EU-wide (TED) · North Rhine-Westphalia · Open procedureDeadline 1 November 2026, today
- TSCM
GLOBAL SECURITY-SECTOR-REFORM FOUNDATION GGMBH
National · North Rhine-Westphalia · Public tender (German national open procedure)Deadline 1 November 2026, today
- IT equipment GPI
GLOBAL SECURITY-SECTOR-REFORM FOUNDATION GGMBH
National · North Rhine-Westphalia · Public tender (German national open procedure)Deadline 1 November 2026, today
- Halde Hoheward, Horizon Observatory, Herten - Refurbishment - Civil Engineering and Paving Works
Contracting authority only with access
EU-wide (TED) · North Rhine-Westphalia · Open procedureDeadline 2 November 2026, 1 day left
Service by CPV code
- 33600000 Pharmaceutical products
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.